Tumorigenic and Mitogenic Capacities Are Reduced in Transfected Fibroblasts Expressing Mutant Insulin-Like Growth Factor (IGF)-I Receptors. The Role of Tyrosine Residues 1250, 1251, and 1316 in the Carboxy-Terminus of the IGF-I Receptor

Endocrinology

Volumn 137, Issue 2, 1996, Pages 410-417

  Blakesley, Vicky A ^a   Kalebic, Thea ^b   Helman, Lee J ^b   Stannard, Bethel ^a   Faria, Teresa N ^a   Roberts Jr , Charles T ^a   Leroith, Derek ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; INSULIN RECEPTOR; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; FIBROBLAST; GENE MUTATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; BASE SEQUENCE; FIBROBLASTS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, NUDE; MITOSIS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, SOMATOMEDIN; THYMIDINE; TRANSFECTION; TYROSINE;

EID: 0030064571     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.2.8593783     Document Type: Article

References (19)

1. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y 1986 Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512
2. Tavare JM, Siddle K 1993 Mutational anlysis of insulin receptor function: consensus and controversy. Biochim Biophys Acta 1178: 21-39
3. Liu D, Zong CS, Wang L-H 1993 Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions. J Virol 67:6835-6840
4. Kaliman P, Baron V, Gautier N, Van Obberghen E 1992 Antipeptide antibody to the insulin-like growth factor-I receptor sequence 1232-1246 inhibits the receptor kinase activity. J Biol Chem 267: 10645-10651
5. Baron V, Gautier N, Komoniya A, Hainan HP, Scimeca JC, Mervic M, Lavialle S, Dolais-Kitagbi J, Van Obberghen E 1990 Insulin binding to its receptor induces a conformational change in the receptor C-terminus. Biochemistry 29:4634-4641
6. Baron V, Gautier N, Kaliman P, Dolais-Kitabgi J, Van Obberghen E 1991 The carboxyl-terminal domain of the insulin receptor: its potential role in growth-promoting effects. Biochemistry 30:9365-9370
7. Levy-Toledano R, Accili D, Taylor SI 1993 Deletion of C-terminal 113 amino acids impairs processing and internalization of human insulin receptor: comparison of receptors expressed in CHO and NIH-3T3 cells. Biochim Biophys Acta 1220:1-14
8. Ellis L, Clauser E, Morgan DO, Edery M, Roth RA, Rutter WJ 1986 Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45:721-732
9. Yamamoto-Honda R, Kadowaki T, Momomura K, Tobe K, Tamori Y, Shibasaki Y, Mori Y, Kaburagi Y, Koshio O, Akanuma Y, Yazaki Y, Kasuga M 1993 Normal insulin receptor substrate-1 phosphorylation in autophosphorylation-defective truncated insulin receptor. Evidence that phosphorylation of substrates might be sufficient for certain biological effects evoked by insulin. J Biol Chem 268:16859-16865
10. Clark S, Konstantopoulos N 1994 Insulin receptor autophosphorylation and exogenous substrate phosphorylation: Role of receptor C-terminus and effects of mild reduction. Biochem Biophys Res Commun 200:330-337
11. Faria TN, Blakesley VA, Kato H, Stannard B, LeRoith D, Roberts Jr CT 1994 Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function. J Biol Chem 269:13922-13928
12. Tartare S, Mothe I, Kowalski-Chauvel A, Breittmayer J-P, Ballotti R, Van Obberghen E 1994 Signal transduction by a chimeric insulin-like growth factor-I (IGF-I) receptor having the carboxyl-terminal domain of the insulin receptor. J Biol Chem 269:11449-11455
13. Kato H, Faria TN, Stannard B, Roberts Jr CT, LeRoith D 1993 Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor: characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (αIR-3). J Biol Chem 268:2655-2661
14. Blakesley VA, Kato H, Roberts Jr CT, LeRoith D 1995 Mutation of a conserved amino acid residue (tryptophan 1173) in the tyrosine kinase domain of the IGF-I receptor abolishes autophosphorylation but does not eliminate biologic function. J Biol Chem 270:2764-2769
15. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
16. Denizot F, Lang R 1986 Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277
17. Munson PJ, Rodbard D 1980 Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239
18. Prager D, Li H-L, Asa S, Melmed S 1994 Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA 91:2181-2185
19. Miura M, Surmacz E, Burgaud J-L, Baserga R 1995 Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J Biol Chem 270:22639-22644